These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37638216)

  • 1. Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study.
    Saad Alshahrani A; Mohammad D; Attieh Alzahrani M; Narula N
    Saudi Pharm J; 2023 Sep; 31(9):101736. PubMed ID: 37638216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis.
    Dalal R; Mitri J; Goodrick H; Allegretti J
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S19. PubMed ID: 37461990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Solanky D; Pardi DS; Loftus EV; Khanna S
    Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease.
    Kosmidou M; Karavasili NT; Saridi M; Skamnelos A; Kavvadias A; Batistatou A; Gartzonika KG; Tsiara S; Katsanos KH; Christodoulou DK
    Mater Sociomed; 2020 Mar; 32(1):41-45. PubMed ID: 32410890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
    Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
    Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
    Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
    Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inflammatory bowel disease with
    D'Aoust J; Battat R; Bessissow T
    World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile in inflammatory bowel disease.
    Alhobayb T; Ciorba MA
    Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and clinical characteristics of Clostridium difficile infection in Saudi patients admitted with inflammatory bowel disease: A case-control study.
    AlKhormi A; Altheyabi AM; AlGhamdi SA; Alshahrani O; Alotay AA; Deeb A
    Saudi J Gastroenterol; 2023; 29(4):251-255. PubMed ID: 37282448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection and inflammatory bowel disease.
    Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
    Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile in inflammatory bowel disease.
    Knyazev OV; Kagramanova AV; Chernova ME; Korneeva IA; Parfenov AI
    Ter Arkh; 2018 Nov; 90(11):32-36. PubMed ID: 30701812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
    Liu Z; Le K; Zhou X; Alexander JL; Lin S; Bewshea C; Chanchlani N; Nice R; McDonald TJ; Lamb CA; Sebastian S; Kok K; Lees CW; Hart AL; Pollok RC; Boyton RJ; Altmann DM; Pollock KM; Goodhand JR; Kennedy NA; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):145-156. PubMed ID: 36481043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
    Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.
    Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q
    J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab.
    Costable NJ; Borman ZA; Ji J; Dubinsky MC; Ungaro RC
    Dig Dis Sci; 2022 Jun; 67(6):2480-2484. PubMed ID: 34021427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
    Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
    J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.